Literature DB >> 21430645

Pregabalin influences insula and amygdala activation during anticipation of emotional images.

Robin L Aupperle1, Lakshmi Ravindran, Dharol Tankersley, Taru Flagan, Nathan R Stein, Alan N Simmons, Murray B Stein, Martin P Paulus.   

Abstract

Pregabalin (PGB) has shown potential as an anxiolytic for treatment of generalized and social anxiety disorder. PGB binds to voltage-dependent calcium channels, leading to upregulation of GABA inhibitory activity and reduction in the release of various neurotransmitters. Previous functional magnetic resonance imaging (fMRI) studies indicate that selective serotonin reuptake inhibitors and benzodiazepines attenuate amygdala, insula, and medial prefrontal cortex activation during anticipation and emotional processing in healthy controls. The aim of this study was to examine whether acute PGB administration would attenuate activation in these regions during emotional anticipation. In this double-blind, placebo-controlled, randomized crossover study, 16 healthy controls completed a paradigm involving anticipation of negative and positive affective images during fMRI approximately 1 h after administration of placebo, 50, or 200 mg PGB. Linear mixed model analysis revealed that PGB was associated with (1) decreases in left amygdala and anterior insula activation and (2) increases in anterior cingulate (ACC) activation, during anticipation of positive and negative stimuli. There was also a region of the anterior amygdala in which PGB dose was associated with increased activation during anticipation of negative and decreased activation during anticipation of positive stimuli. Attenuation of amygdala and insula activation during anticipatory or emotional processing may represent a common regional brain mechanism for anxiolytics across drug classes. PGB induced increases in ACC activation could be a unique effect related to top-down modulation of affective processing. These results provide further support for the viability of using pharmaco-fMRI to determine the anxiolytic potential of pharmacologic agents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21430645      PMCID: PMC3096815          DOI: 10.1038/npp.2011.32

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  70 in total

Review 1.  The amygdala: vigilance and emotion.

Authors:  M Davis; P J Whalen
Journal:  Mol Psychiatry       Date:  2001-01       Impact factor: 15.992

Review 2.  Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission.

Authors:  David J Dooley; Charles P Taylor; Sean Donevan; Douglas Feltner
Journal:  Trends Pharmacol Sci       Date:  2007-01-10       Impact factor: 14.819

Review 3.  Neurobiology of emotion perception I: The neural basis of normal emotion perception.

Authors:  Mary L Phillips; Wayne C Drevets; Scott L Rauch; Richard Lane
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

4.  A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder.

Authors:  Kristin Mitte; Peter Noack; Regina Steil; Martin Hautzinger
Journal:  J Clin Psychopharmacol       Date:  2005-04       Impact factor: 3.153

5.  Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study.

Authors:  Siegfried Kasper; Dan J Stein; Henrik Loft; Rico Nil
Journal:  Br J Psychiatry       Date:  2005-03       Impact factor: 9.319

6.  Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

Authors:  Atul C Pande; Jerri G Crockatt; Douglas E Feltner; Carol A Janney; Ward T Smith; Richard Weisler; Peter D Londborg; Robert J Bielski; Dan L Zimbroff; Jonathan R T Davidson; Maria Liu-Dumaw
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

Review 7.  Room for improvement in the pharmacological treatment of anxiety disorders.

Authors:  D S Baldwin
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 8.  Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.

Authors:  Meera Vaswani; Farzana Kadar Linda; Subramanyam Ramesh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-02       Impact factor: 5.067

9.  Right anterior insula hypoactivity during anticipation of homeostatic shifts in major depressive disorder.

Authors:  Irina A Strigo; Scott C Matthews; Alan N Simmons
Journal:  Psychosom Med       Date:  2010-01-25       Impact factor: 4.312

10.  The relationship between amygdala activation and passive exposure time to an aversive cue during a continuous performance task.

Authors:  Irina A Strigo; Alan N Simmons; Scott C Matthews; Arthur D Bud Craig
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

View more
  16 in total

1.  Social status modulates the neural response to unfairness.

Authors:  Jie Hu; Philip R Blue; Hongbo Yu; Xiaoliang Gong; Yang Xiang; Changjun Jiang; Xiaolin Zhou
Journal:  Soc Cogn Affect Neurosci       Date:  2015-07-02       Impact factor: 3.436

2.  Neural correlates of aversive anticipation: An activation likelihood estimate meta-analysis across multiple sensory modalities.

Authors:  Jeremy A Andrzejewski; Tsafrir Greenberg; Joshua M Carlson
Journal:  Cogn Affect Behav Neurosci       Date:  2019-12       Impact factor: 3.282

Review 3.  Cortical and subcortical gamma amino acid butyric acid deficits in anxiety and stress disorders: Clinical implications.

Authors:  Andrew W Goddard
Journal:  World J Psychiatry       Date:  2016-03-22

4.  Neural dysregulation in posttraumatic stress disorder: evidence for disrupted equilibrium between salience and default mode brain networks.

Authors:  Rebecca K Sripada; Anthony P King; Robert C Welsh; Sarah N Garfinkel; Xin Wang; Chandra S Sripada; Israel Liberzon
Journal:  Psychosom Med       Date:  2012-10-31       Impact factor: 4.312

5.  The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice.

Authors:  Dean T Acheson; Murray B Stein; Martin P Paulus; Mark A Geyer; Victoria B Risbrough
Journal:  Neuropharmacology       Date:  2012-05-02       Impact factor: 5.250

6.  Neural affective mechanisms associated with treatment responsiveness in veterans with PTSD and comorbid alcohol use disorder.

Authors:  Katia M Harlé; Alan N Simmons; Sonya B Norman; Andrea D Spadoni
Journal:  Psychiatry Res Neuroimaging       Date:  2020-08-20       Impact factor: 2.376

7.  Pregabalin for the treatment of generalized anxiety disorder: an update.

Authors:  David S Baldwin; Khalil Ajel; Vasilios G Masdrakis; Magda Nowak; Rizwan Rafiq
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-24       Impact factor: 2.570

8.  Pregabalin effects on neural response to emotional faces.

Authors:  Robin L Aupperle; Dharol Tankersley; Lakshmi N Ravindran; Taru Flagan; Nathan R Stein; Murray B Stein; Martin P Paulus
Journal:  Front Hum Neurosci       Date:  2012-03-27       Impact factor: 3.169

Review 9.  Neuroimaging in anxiety disorders.

Authors:  Kathrin Holzschneider; Christoph Mulert
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

10.  Decreased startle modulation during anticipation in the postpartum period in comparison to late pregnancy.

Authors:  Charlotte Hellgren; Elin Bannbers; Helena Åkerud; Victoria Risbrough; Inger Sundström Poromaa
Journal:  Arch Womens Ment Health       Date:  2012-04       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.